Kevin Patrick Danahy, Chief Commercial Officer: Pulse Biosciences PLSE Planned sale · Filed 02/12

Trade details

Type: Planned sale notice
Stock: Pulse Biosciences PLSE
Person: Kevin Patrick DanahyChief Commercial Officer
Planned sale date: 26/02/12
Filed: 26/02/12

More to sell after $1.4M in 3 months

Pulse Biosciences trades, last 26 weeks

What else happened in Pulse Biosciences around then

Filed or reported within 30 days of the trade day · 01/13~03/14

Kevin Patrick Danahy's recent trades

Kevin Patrick DanahyChief Commercial Officer
Sell10b5-1 planPulse Biosciences
Sell10b5-1 plan
Pulse Biosciences
PLSE
$118.2K
5,000 sh
$118.2K
Filed 02/23
Traded 02/18
Kevin Patrick DanahyChief Commercial Officer
Sell10b5-1 planPulse Biosciences
Sell10b5-1 plan
Pulse Biosciences
PLSE
$472.6K
20,000 sh
$472.6K
Filed 02/17
Traded 02/17
Kevin Patrick DanahyChief Commercial Officer
Sell10b5-1 planPulse Biosciences
Sell10b5-1 plan
Pulse Biosciences
PLSE
$470.6K
20,000 sh
$470.6K
Filed 02/17
Traded 02/13
Kevin Patrick DanahyChief Commercial Officer
Sell10b5-1 planPulse Biosciences
Sell10b5-1 plan
Pulse Biosciences
PLSE
$467.4K
20,000 sh
$467.4K
Filed 02/17
Traded 02/12
Kevin Patrick DanahyChief Commercial Officer
Sell10b5-1 planPulse Biosciences
Sell10b5-1 plan
Pulse Biosciences
PLSE
$504K
20,000 sh
$504K
Filed 02/11
Traded 02/11

Kevin Patrick Danahy, Chief Officer — plans to sell 50,000 sh of Pulse Biosciences PLSE · $1.3M · around 02/12 · 10b5-1 plan | Whalegun